CERT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Certara Inc (CERT) is not a good buy for a beginner, long-term investor at this time. The stock is in a bearish trend with no strong positive catalysts, weak financial performance, and mixed to negative analyst sentiment. The lack of recent trading signals and absence of significant news or influential trading activity further supports a hold recommendation.
The technical indicators suggest a bearish trend. The MACD is negatively expanding, RSI is at 13.914 indicating oversold conditions, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 5.4, with resistance levels at 6.305 and 6.585.
The company remains uniquely positioned in model-informed drug development, as highlighted by UBS. Gross margin increased slightly YoY to 48.26%.
Q4 financials showed a significant drop in net income (-189.63% YoY) and EPS (-200.00% YoY). Analysts have lowered price targets, with multiple downgrades to Neutral or Hold ratings. The company's 2026 guidance challenges the Buy thesis. There is no recent news or significant trading activity from insiders, hedge funds, or Congress.
In Q4 2025, revenue increased by 3.28% YoY to $103.65M, but net income dropped significantly to -$5.89M, and EPS fell to -0.04. Gross margin improved slightly by 0.67% YoY.
Analysts have mixed to negative sentiment. UBS maintains a Buy rating but lowered the price target to $10. Barclays downgraded the stock to Equal Weight with an $8 price target. Other firms have also reduced price targets, citing concerns about growth, execution, and valuation support.
